basal expression
1.BALB/c mice were immunized with these plasmids and doxycycline (dox) was administered to regulate the expression of AMA 1. For some mice immunized with pTL 8/AMA 1(rtTA), pUHS6 1, a plasmid containing trans silencer (tTS) to suppress basal expression of AMA 1 from pTL 8/AMA 1(rtTA), was injected into these mice together with pTL 8/AMA 1(rtTA).
2.Objective: To study the relationship between mast cell (MC) and skin basal cell carcinoma (BCC) PCNA expression.
3.Objectives: To investigate the expression of CD147/basagin in eyelid basal cell carcinoma(BCC) and the correlation between its expression and prognosis.
4.Objective:To explore the effection of Bcl-2, Bax, Bcl-xl proteins oncarcinogencsis and development of Basal cell carcinoma(BCC), theirimmunoh istochemical expression were studied.
5.Conclusion Anisodamine inhibits both basal and LPS induced PAI 1 protein as well as mRNA expression in ECs.
6.Bcl 2 protein was detected with immunohistochemical method in basal cell carcinoma(BCC), and compared with expression of p53 protein, Pan ras protein as well as proliferating cell nuclear antigen(PCNA).
7.Ets-1 interacted selectively with the ~ -1350GGAA~ -1347 Ets element in the P21WAF1/CIP1 promoter. Mutation of this element reduced basal and Ets-1-inducible P21WAF1/CIP1 promoter-dependent expression.
8.Purpose (1)To investigate the expression of NES1 gene and protein in eyelid basal cell carcinoma (BCC),and analyze the correlation between its expression and the tumorigenic phenotype. In addition, to study the role of NES1 in oncogenesis and progression of eyelid basal cell carcinoma at gene and protein level, and estimate the feasibility as a tumor marker in the early diagnosis and prognosis.
9.Quantitative Analysis of Bcl-2,Bax, Bcl-xl Expression in Basal Cell Carcinoma with Immunohistochemistry
